Top Broker Regulation Stories
How PBM "rebate walls" impact drug spending, patient care and competition
By Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS, Jesse C. Dresser, Esq., Andreas Stargard, Esq.Federal agencies and plan sponsors—the clients of PBMs—are beginning to explore perverse PBM incentives and are waking up to abusive PBM practices.









